Genmab — September 2018
-
"In conclusion, the combination of daratumumab, lenalidomide, and dexamethasone may currently be the most effective regimen in the population of RRMM patients." https://www.oncologynurseadvisor.com/navigator-notes/triplet-regimen-found-most-effective-for-rrmm/article/795972/ https://www.dovepress.com/treatment-options-for-refractoryrelapsed-multiple-myeloma-an-updated-e-peer-reviewed-fulltext-article-CMAR
-
Kinase inhibitor advances in MM: predictive biomarkers & efficacy of daratumumab https://www.vjhemonc.com/video/m_o9uyu8d00-kinase-inhibitor-advances-in-mm-predictive-biomarkers-efficacy-of-daratumumab/
-
Multiple myeloma: 2018 update on diagnosis, risk‐stratification, and management - Vincent Rajkumar - https://onlinelibrary.wiley.com/doi/10.1002/ajh.25117
-
Hvad siger TA om Genmab lige nu: http://www.proinvestor.com/?p=debat_1&postid=76167&thread=50&start=
-
Det har jeg misset.
-
Host..;-)
-
Weekendlæsning:
http://www.proinvestor.com/index.php?p=debat_1&postid=76169 -
Genmabs situation i en nøddeskal https://www.youtube.com/watch?v=VMuEis3byY4&feature=youtu.be
-
Tak Stockbull. Jeg har lagt den i debatten.
-
Servicemeddelelse: Ny analysevideo på Zealand Pharma i debatten.
http://www.proinvestor.com/?p=debat_1&postid=76173&thread=50&start= -
God morgen.
-
God morgen
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind